Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-31

Clinical Trial Update: Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

View source ↗

Summary

Long-term effectiveness and immuno-persistence study of a recombinant HPV 16/18 bivalent vaccine in preadolescent girls; the trial status is ACTIVE_NOT_RECRUITI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: Xiamen University | Conditions: Cervical Intraepithelial Neoplasia, Cervical Cancer | Status: ACTIVE_NOT_RECRUITING